ES2398478T5 - Sales solubles estables de ácido fenilbencimidazolsulfónico de pH 6,0 a menos de 6,8 - Google Patents

Sales solubles estables de ácido fenilbencimidazolsulfónico de pH 6,0 a menos de 6,8 Download PDF

Info

Publication number
ES2398478T5
ES2398478T5 ES07787271.1T ES07787271T ES2398478T5 ES 2398478 T5 ES2398478 T5 ES 2398478T5 ES 07787271 T ES07787271 T ES 07787271T ES 2398478 T5 ES2398478 T5 ES 2398478T5
Authority
ES
Spain
Prior art keywords
acid
water
neo heliopan
propylene glycol
phenylbenzimidazolsulfonic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07787271.1T
Other languages
English (en)
Spanish (es)
Other versions
ES2398478T3 (es
Inventor
William Johncock
Jürgen Claus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Symrise AG
Original Assignee
Symrise AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38723648&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2398478(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Symrise AG filed Critical Symrise AG
Publication of ES2398478T3 publication Critical patent/ES2398478T3/es
Application granted granted Critical
Publication of ES2398478T5 publication Critical patent/ES2398478T5/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
ES07787271.1T 2007-07-09 2007-07-09 Sales solubles estables de ácido fenilbencimidazolsulfónico de pH 6,0 a menos de 6,8 Active ES2398478T5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2007/056995 WO2007135196A2 (en) 2007-07-09 2007-07-09 Stable soluble salts of phenylbenzimidazole sulfonic acid at phs at or below 7.0

Publications (2)

Publication Number Publication Date
ES2398478T3 ES2398478T3 (es) 2013-03-19
ES2398478T5 true ES2398478T5 (es) 2016-02-25

Family

ID=38723648

Family Applications (1)

Application Number Title Priority Date Filing Date
ES07787271.1T Active ES2398478T5 (es) 2007-07-09 2007-07-09 Sales solubles estables de ácido fenilbencimidazolsulfónico de pH 6,0 a menos de 6,8

Country Status (5)

Country Link
US (1) US8440172B2 (de)
EP (1) EP2178493B2 (de)
BR (1) BRPI0721862B1 (de)
ES (1) ES2398478T5 (de)
WO (1) WO2007135196A2 (de)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7407955B2 (en) * 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (de) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG Zusammensetzungen von DPP-IV-Inhibitoren
CN109503584A (zh) 2006-05-04 2019-03-22 勃林格殷格翰国际有限公司 多晶型
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
JP5382904B2 (ja) * 2008-02-19 2014-01-08 株式会社 資生堂 油中水型乳化日焼け止め化粧料
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
DE102008025576A1 (de) * 2008-05-28 2009-12-03 Henkel Ag & Co. Kgaa Sonnenschutzzusammensetzungen
DE102008063288A1 (de) 2008-12-29 2010-07-01 Henkel Ag & Co. Kgaa Sonnenschutzzusammensetzungen
DE102008063307A1 (de) 2008-12-29 2010-07-01 Henkel Ag & Co. Kgaa Sonnenschutzzusammensetzungen
KR20190016601A (ko) 2008-08-06 2019-02-18 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
WO2010029089A2 (en) 2008-09-10 2010-03-18 Boehringer Ingelheim International Gmbh Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
EP2382216A1 (de) 2008-12-23 2011-11-02 Boehringer Ingelheim International GmbH Salzformen einer organischen verbindung
EP2201927A3 (de) 2008-12-29 2013-05-22 Henkel AG & Co. KGaA Sonnenschutzzusammensetzungen
DE102008063306A1 (de) 2008-12-29 2010-07-01 Henkel Ag & Co. Kgaa Sonnenschutzzusammensetzungen
DE102009045998A1 (de) 2009-10-26 2011-04-28 Henkel Ag & Co. Kgaa Sonnenschutzzusammensetzungen
TW201036975A (en) 2009-01-07 2010-10-16 Boehringer Ingelheim Int Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
US20100272658A1 (en) 2009-04-27 2010-10-28 Akzo Nobel Chemicals International B.V. Enhanced efficiency of sunscreen compositions
DE102009026414A1 (de) 2009-05-22 2010-11-25 Henkel Ag & Co. Kgaa Hautbehandlung zur Porenverfeinerung
AR079182A1 (es) * 2009-06-16 2012-01-04 Grace W R & Co Oxidos metalicos cationico - compatibles y composiciones para cuidado bucodental que contienen los oxidos metalicos
US11052029B2 (en) 2009-06-16 2021-07-06 W. R. Grace & Co.-Conn. Cation compatible metal oxides and oral care compositions containing the metal oxides
EP2467122A2 (de) * 2009-08-21 2012-06-27 Blueshift Pharma GmbH Lichtreaktive sonnenschutzzusammensetzung
EP2295114A1 (de) 2009-09-10 2011-03-16 Dalli-Werke GmbH & Co. KG Kosmetische Zusammensetzung mit antimikrobieller Wirkung
BR112012008213B1 (pt) * 2009-10-09 2022-02-22 Isp Investments Llc Composição de proteção solar
NZ599298A (en) 2009-11-27 2014-11-28 Boehringer Ingelheim Int Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
JP4834775B2 (ja) * 2010-03-04 2011-12-14 株式会社 資生堂 日焼け止め用組成物
US20120012127A1 (en) * 2010-04-01 2012-01-19 L'oreal Cosmetic compositions containing arginine and a preservative system containing an alcohol
KR101927068B1 (ko) 2010-05-05 2018-12-10 베링거 인겔하임 인터내셔날 게엠베하 체중 감소 치료에 후속하는 dpp-4 억제제에 의한 순차적 병용 요법
EP2394703B1 (de) * 2010-06-14 2015-12-23 Symrise AG Kühlmischungen mit verstärkter Kühlwirkung von 5-Methyl-2-(propan-2-yl)cyclohexyl-N-ethyloxamat
CN106975074A (zh) 2010-06-24 2017-07-25 勃林格殷格翰国际有限公司 糖尿病治疗
DE102010044681A1 (de) * 2010-09-08 2012-03-08 Beiersdorf Ag Stabilisierte Emulsion
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
ES2713566T3 (es) 2011-07-15 2019-05-22 Boehringer Ingelheim Int Derivado de quinazolina dimérico sustituido, su preparación y su uso en composiciones farmacéuticas para el tratamiento de la diabetes de tipo I y II
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
EP3685839A1 (de) 2012-05-14 2020-07-29 Boehringer Ingelheim International GmbH Linagliptin zur verwendung in der behandlung von albuminuria und nierenbedingten erkrankungen
EP4151218A1 (de) 2012-05-14 2023-03-22 Boehringer Ingelheim International GmbH Linagliptin, ein xanthinderivat als dpp-4-inhibitor zur verwendung bei der behandlung von sirs und/oder sepsis
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
US20160115136A1 (en) * 2013-03-13 2016-04-28 University Of Iowa Research Foundation Compounds, compositions comprsing same, and methods related thereto
DE102014201541A1 (de) 2014-01-29 2015-07-30 Beiersdorf Ag Octocrylenfreies Sonnenschutzmittel mit geringer Klebrigkeit
US9526728B2 (en) 2014-02-28 2016-12-27 Boehringer Ingelheim International Gmbh Medical use of a DPP-4 inhibitor
US10823467B2 (en) * 2015-03-30 2020-11-03 Carrier Corporation Low-oil refrigerants and vapor compression systems
DE102015208866A1 (de) 2015-05-13 2016-11-17 Beiersdorf Ag Octocrylenfreies Sonnenschutzmittel enthaltend Diethylaminohydroxybenzoylhexylbenzoat
EP4233840A3 (de) 2016-06-10 2023-10-18 Boehringer Ingelheim International GmbH Kombinationen aus linagliptin und metformin
EP3315488A1 (de) * 2016-10-28 2018-05-02 Elé Corporation Aminosäurebasiertes amphoteres tensid
CA3047495A1 (en) 2016-12-21 2018-06-28 Unilever Plc Topical skin lightening additive and composition with amino acids and nicotinamide compounds
EP3558246B1 (de) 2016-12-21 2021-10-20 Unilever IP Holdings B.V. Körperpflegezusammensetzungen mit glutathionvorläufer mit 4-substituierten resorcinolen und aminosäuren
JP7082623B2 (ja) 2016-12-21 2022-06-08 ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ シスチンを有するパーソナルケア用組成物
EP3558243B1 (de) 2016-12-21 2022-10-05 Unilever IP Holdings B.V. Körperpflegezusammensetzungen mit schwerlöslichen verbindungen
US10660838B2 (en) 2017-06-23 2020-05-26 The Procter & Gamble Company Composition and method for improving the appearance of skin
JP2021524848A (ja) * 2018-05-18 2021-09-16 ディーエスエム アイピー アセッツ ビー.ブイ.Dsm Ip Assets B.V. 局所組成物
EP3773422B1 (de) 2018-05-23 2021-11-10 Unilever IP Holdings B.V. Nanoemulsionen und verfahren zur herstellung davon
CN112437657A (zh) 2018-07-03 2021-03-02 宝洁公司 处理皮肤状况的方法
EP3840721A1 (de) 2018-08-23 2021-06-30 The Procter & Gamble Company Hautpflegezusammensetzung
CN115843238B (zh) 2020-06-01 2025-06-10 宝洁公司 改善维生素b3化合物渗透到皮肤中的方法
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
WO2022067402A1 (en) * 2020-09-30 2022-04-07 L'oreal Aqueous gel cosmetic sunscreen composition, process for manufacturing the aqueous gel cosmetic sunscreen composition and the use of the aqueous gel cosmetic sunscreen composition
WO2022189293A1 (en) * 2021-03-12 2022-09-15 Dsm Ip Assets B.V. Sunscreen composition
WO2022268415A1 (en) 2021-06-24 2022-12-29 Unilever Ip Holdings B.V. Cosmetic composition with enhanced color stability
JP2024544080A (ja) * 2021-12-16 2024-11-27 ザ プロクター アンド ギャンブル カンパニー ヘアコンディショニング組成物
WO2023235942A1 (en) * 2022-06-10 2023-12-14 L'oreal Cosmetic sunscreen composition and use of a cosmetic sunscreen composition
WO2024110023A1 (en) * 2022-11-23 2024-05-30 Symrise Ag An active composition comprising retinol
JP2025536731A (ja) * 2022-11-25 2025-11-07 エルブイエムエイチ レシェルシェ 液状油中水型エマルジョン化粧料組成物
CN117442508B (zh) * 2023-11-27 2025-03-11 无锡知妍生物科技有限公司 一种兼具舒缓功效的可溶性壬二酸超分子组合体系
WO2025234031A1 (en) * 2024-05-08 2025-11-13 Lvmh Recherche Water-in-oil emulsified cosmetic compositions comprising a sulfonic acid-based organic ultraviolet absorber
WO2026013172A1 (en) * 2024-07-12 2026-01-15 Unilever Ip Holdings B.V. A personal care composition
WO2026013175A1 (en) * 2024-07-12 2026-01-15 Unilever Ip Holdings B.V. A personal care composition

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU70487A1 (de) 1974-07-08 1976-05-31
DE3314742C2 (de) 1983-04-23 1987-04-02 Degussa Ag, 6000 Frankfurt Verfahren zur Herstellung von an der Oberfläche modifizierten natürlichen, oxidischen oder silikatischen Füllstoffen und deren Verwendung
JPS6130567A (ja) 1984-07-23 1986-02-12 Shiseido Co Ltd 尿素の安定化法
FR2587900B1 (fr) 1985-10-01 1988-10-07 Morelle Jean Associations acides gras-acides amines basiques, douees de proprietes emollientes, emulsifiantes et antioxydantes, destinees a la cosmetique, la dermatologie et l'alimentation
KR900000847B1 (ko) 1987-12-24 1990-02-17 주식회사 럭키 변색방지효과를 증진시킨 화장품 조성물
DE4341001A1 (de) 1993-12-02 1995-06-08 Beiersdorf Ag Topische Zubereitungen mit einem Gehalt an L-Arginin
FR2726468B1 (fr) 1994-11-03 1996-12-13 Oreal Utilisation de derive de l'acide salicylique comme stabilisant d'une emulsion huile-dans-eau
US6153176A (en) 1995-01-20 2000-11-28 The Procter & Gamble Company Low pH sunscreen compositions
US5734080A (en) 1995-09-22 1998-03-31 Anihealth Corporation Reaction product of arginine and p-aminobenzoic acid, cosmetic, and human and animal health compositions thereof
DE19713776A1 (de) 1997-04-03 1998-10-08 Beiersdorf Ag Lichtschutzzubereitungen mit einem Gehalt an basischen Aminosäuren und wasserlöslichen UV-Filtersubstanzen
DE19757826A1 (de) 1997-12-24 1999-07-01 Beiersdorf Ag Neue Verwendung von chaotropen Verbindungen und chaotrope Verbindungen enthaltende Zubereitungen
DE19857252A1 (de) 1998-12-11 2000-06-15 Haarmann & Reimer Gmbh Benzyliden-gamma-butyrolactone, Verfahren zu ihrer Herstellung und ihre Verwendung als UV-Absorber
FR2791564B1 (fr) 1999-04-02 2004-09-10 Jean Morelle Compositions destinees a la protection de la peau contre l'agression oxydative des radiations solaires
DE10055940A1 (de) 2000-11-10 2002-05-29 Bayer Ag Neue Indanylidenverbindungen
DE10141780A1 (de) * 2001-08-25 2003-03-06 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Histidin zum Erhalt oder zur Steigerung des Urocaninsäurestatus der Haut
DE10141789B4 (de) 2001-08-25 2007-02-22 Dr.Ing.H.C. F. Porsche Ag Kraftfahrzeug, insbesondere Personenwagen, mit einer am Aufbau des Kraftfahrzeugs über eine Scharniereinrichtung schwenkbar angelenkten Klappe
MC200053A1 (fr) 2002-01-04 2002-07-29 A M Exsymol S Utilisation de derives de la L-arginine comme agents photoprotecteurs et optimisant la reponse melanique dans des compositions cosmetiques
DE102004029239A1 (de) 2004-05-03 2005-12-01 Symrise Gmbh & Co. Kg Benyliden-β-dicarbonylverbindungen als neue UV-Absorber
DE102004038485A1 (de) 2004-08-07 2006-02-23 Symrise Gmbh & Co. Kg alpha-Benzoyl-zimtsäurenitrile als neue UV-Absorber

Also Published As

Publication number Publication date
WO2007135196A3 (en) 2008-05-02
WO2007135196A2 (en) 2007-11-29
ES2398478T3 (es) 2013-03-19
US20100183531A1 (en) 2010-07-22
EP2178493B2 (de) 2015-12-09
EP2178493A2 (de) 2010-04-28
BRPI0721862A2 (pt) 2013-03-05
US8440172B2 (en) 2013-05-14
BRPI0721862B1 (pt) 2016-03-15
EP2178493B1 (de) 2012-12-12

Similar Documents

Publication Publication Date Title
ES2398478T5 (es) Sales solubles estables de ácido fenilbencimidazolsulfónico de pH 6,0 a menos de 6,8
ES2634638T3 (es) Uso de troxerutina para desactivar la fluorescencia del tetrasulfonato de fenildibencimidazol disódico
US9889078B2 (en) Skin and/or hair whitening mixture
US9517190B2 (en) Coated titanium dioxide to reduce the whitening effect on skin
ES2819207T3 (es) Mezclas activas
JP2023552597A (ja) 抗微生物剤および(バイオ)-アルカンジオールを含む、皮膚保護用組成物
AU2018411527B2 (en) Mixtures comprising a protein extract for the treatment of human skin and/or hair
US20030108493A1 (en) Extracts from residues left in the production of wine
CN116615172A (zh) 包含天然聚合物和一种或多种(生物)烷二醇的组合物
US20030129150A1 (en) Cosmetic preparations containing plant extracts
AU2021393980B2 (en) Compositions comprising uv-filters and one or more (bio)-alkanediols
US20060078568A1 (en) Use of the residues from wine production
WO2010072810A1 (en) Mixture of amides and cosmetic compositions comprising said mixture
US9066880B2 (en) Use of dihydrodehydrodiisoeugenol and preparations comprising dihydrodehydrodiisoeugenol
EP2862852B1 (de) Harnstoffderivate für den Schutz von Stammzellen
CN120500321A (zh) 润肤剂共混物